| Financial Year |
March 31 2023 |
| Monetary Funds |
299,807,696.69 |
| Held-for-trading Financial Assets |
331,173,759.26 |
| Notes Receivable |
2,428,022.73 |
| Accounts Receivable |
220,321,694.38 |
| Advances to Suppliers |
1,386,832.43 |
| Other Receivables |
35,964,715.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,822,028.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,352,011.86 |
| Total Current Assets |
980,088,507.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,701,729.18 |
| Investment Properties |
15,518,174.61 |
| Fixed Assetes |
660,206,093.83 |
| Under-construction Projects |
14,568,558.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
144,173,364.97 |
| R&D expenses |
-- |
| Goodwill |
14,522,238.39 |
| Long-Term Deferred and Prepaid Expenses |
3,278,364.17 |
| Deferred Income Tax Assets |
5,064,108.61 |
| Other Non-Current Assets |
1,244,826.02 |
| Sub-Total of Non-Current Assets |
1,069,993,204.62 |
| Total Assets |
2,050,081,711.91 |
| Short-Term Loans |
99,290,217.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,000,000.00 |
| Accounts Payable |
34,059,443.35 |
| Accounts Received In Advance |
515,216.70 |
| Employee Compensation Payable |
8,111,566.27 |
| Taxes Payable |
7,696,892.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,316,005.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,296,010.75 |
| Other Current Liabilities |
705,548.86 |
| Sub-Total of Current Liabilities |
211,118,706.92 |
| Long-term Loans |
53,863,414.59 |
| Bonds Payable |
79,614,255.78 |
| Long-Term Accounts Payable |
100,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,989,254.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
169,002,882.43 |
| Total Liabilities |
380,121,589.35 |
| Paid-In Capital(Or Share Stock) |
405,000,000.00 |
| Capital Surplus |
419,841,382.03 |
| Surplus Reserve |
68,414,551.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
711,283,751.86 |
| Minority Stockholder's Interest |
14,956,510.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,655,003,612.31 |
| Owner's Equity（Stockholder's Equity） |
1,669,960,122.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,050,081,711.91 |
